Effectiveness of a Prehabilitation Program for Hip or Knee Arthroplasty Surgery.
Preoperative
1 other identifier
interventional
44
1 country
1
Brief Summary
We live in an increasingly aging society in which the incidence of osteoarticular diseases increases, among which osteoarthritis (OA) stands out. OA is a degenerative disorder of the different components of the joint leading to a progressive destruction of the same. The hip and knee being the most affected joints, OA presents multiple symptoms such as pain, stiffness and functional limitation, also causing psychological disorders such as anxiety, depression, quality of sleep and poor perception of quality of life. Conventional treatment is aimed at alleviating symptoms, but when conservative therapies fail in the more advanced stages of the disease, total joint replacement surgery or arthroplasty is the therapeutic option of choice. Strength physical exercise (PE) and aerobic training have been shown to be effective in OA, obtaining positive effects on the symptoms and on variables that deteriorate this disease. The concept of pre-habilitation or preoperative rehabilitation has been shown through other studies in different pathologies (cardiopulmonary and musculoskeletal) to have positive effects at a clinical and functional level, however, the planning of a pre-habilitation protocol in hip or knee arthroplasty is still controversial. The purpose of this study is to determine the effect that a prehabilitation program will produce and its possible usefulness in those subjects who are waiting for a hip or knee arthroplasty. It is expected to find favorable results that support this therapy when it comes to reducing postoperative recovery times, functional capacity and other psychological variables of interest. This powerful tool could represent a non-pharmacological and non-invasive therapy, as well as being useful and economical in the management of patients with OA in advanced stages.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 28, 2024
CompletedFirst Posted
Study publicly available on registry
December 6, 2024
CompletedStudy Start
First participant enrolled
May 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2027
February 13, 2026
January 1, 2026
1.5 years
November 28, 2024
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measuring Quality of life
SF-12 Health Questionnaire: This is a valid instrument for measuring health-related quality of life (HRQoL). The SF-12 is a reduced version of the SF-36 questionnaire, consisting of a subset of 12 items from the SF-36, selected by multiple regression, including 1 or 2 items from each of the 8 domains of the SF-36. From the information obtained from these 12 items, the SF-12 physical and mental summary measures are obtained as the only assessments. The assessments vary between 0 (no quality of life) and 100 (maximum quality of life).
Start of the study and week 24
Secondary Outcomes (16)
Lower limb functionality
Start of study, week 6, week 9 and week 24
Lower limb functionality
Start of study, week 6, week 9 and week 24.
Strength
Start of study, week 6, week 9 and week 24 (end of intervention).
Strength
Start of the study, week 6, week 9 and week 24 (end of the intervention)
Level of perceived exertion
From the start of the prehabilitation program until 6 weeks (end of the prehabilitation program)
- +11 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALThe intervention group (IG) will undergo a 6-week prehabilitation program for total hip/knee replacement surgery. Once the surgery is complete, they will follow the same rehabilitation program proposed for the control group.
Control Group
EXPERIMENTALThe control group (CG) will carry out a post-operative physiotherapy program in addition to a home exercise program that will be shown by the physiotherapist before hospital discharge.
Interventions
A prehabilitation programme supervised by a physiotherapist in a ward is proposed, with a frequency of 3 sessions/week on alternate days lasting 30-45 min/session, in addition to a daily physical exercise programme at home. The programme will consist of a warm-up, strength exercises with progressive loads, proprioception, balance, cardiovascular training aimed at functional work and a cool-down. The home programme will be complementary to the supervised programme, which will consist of daily sessions of 20-30 min of flexibility and proprioception exercises. The same prehabilitation protocol will be proposed for those patients awaiting total hip and knee replacement surgery.
The control group (CG) will carry out a post-operative physiotherapy program in addition to a home exercise program that will be shown by the physiotherapist before hospital discharge.
Eligibility Criteria
You may qualify if:
- Diagnosis of hip OA stage I-III of the Tönnis classification or diagnosis of knee OA stage I-IV of the Ahlbäck classification
- Patients requiring hip/knee arthroplasty surgery
- Signed informed consent
- Obtaining a score equal to or greater than 8 repetitions in the Sit to Stand test
- Patients with the ability to walk without technical aids or in need of some help (up to two canes or a walker)
You may not qualify if:
- Cognitive deficit/Dementia states
- Cancer processes
- Associated vascular and inflammatory pathologies
- Associated neurological pathologies
- Contraindications to physical exercise
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Jaénlead
- Hospital Clinico Universitario San Ceciliocollaborator
Study Sites (1)
Hospital Universitario San Cecilio- Distrito Sanitario Metropolitano Granada
Granada, 18012, Spain
Related Publications (16)
Granicher P, Mulder L, Lenssen T, Fucentese SF, Swanenburg J, De Bie R, Scherr J. Exercise- and education-based prehabilitation before total knee arthroplasty: a pilot study. J Rehabil Med. 2024 Jan 8;56:jrm18326. doi: 10.2340/jrm.v56.18326.
PMID: 38192160BACKGROUNDFranz A, Ji S, Bittersohl B, Zilkens C, Behringer M. Impact of a Six-Week Prehabilitation With Blood-Flow Restriction Training on Pre- and Postoperative Skeletal Muscle Mass and Strength in Patients Receiving Primary Total Knee Arthroplasty. Front Physiol. 2022 Jun 14;13:881484. doi: 10.3389/fphys.2022.881484. eCollection 2022.
PMID: 35774280BACKGROUNDSwank AM, Kachelman JB, Bibeau W, Quesada PM, Nyland J, Malkani A, Topp RV. Prehabilitation before total knee arthroplasty increases strength and function in older adults with severe osteoarthritis. J Strength Cond Res. 2011 Feb;25(2):318-25. doi: 10.1519/JSC.0b013e318202e431.
PMID: 21217530BACKGROUNDMcKay C, Prapavessis H, Doherty T. The effect of a prehabilitation exercise program on quadriceps strength for patients undergoing total knee arthroplasty: a randomized controlled pilot study. PM R. 2012 Sep;4(9):647-56. doi: 10.1016/j.pmrj.2012.04.012. Epub 2012 Jun 13.
PMID: 22698852BACKGROUNDVitaloni M, Botto-van Bemden A, Sciortino Contreras RM, Scotton D, Bibas M, Quintero M, Monfort J, Carne X, de Abajo F, Oswald E, Cabot MR, Matucci M, du Souich P, Moller I, Eakin G, Verges J. Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review. BMC Musculoskelet Disord. 2019 Oct 27;20(1):493. doi: 10.1186/s12891-019-2895-3.
PMID: 31656197BACKGROUNDNguyen C, Boutron I, Roren A, Anract P, Beaudreuil J, Biau D, Boisgard S, Daste C, Durand-Zaleski I, Eschalier B, Gil C, Lefevre-Colau MM, Nizard R, Perrodeau E, Rabetrano H, Richette P, Sanchez K, Zalc J, Coudeyre E, Rannou F. Effect of Prehabilitation Before Total Knee Replacement for Knee Osteoarthritis on Functional Outcomes: A Randomized Clinical Trial. JAMA Netw Open. 2022 Mar 1;5(3):e221462. doi: 10.1001/jamanetworkopen.2022.1462.
PMID: 35262716BACKGROUNDDong Y, Yan Y, Zhou J, Zhou Q, Wei H. Evidence on risk factors for knee osteoarthritis in middle-older aged: a systematic review and meta analysis. J Orthop Surg Res. 2023 Aug 29;18(1):634. doi: 10.1186/s13018-023-04089-6.
PMID: 37641050BACKGROUNDJahic D, Omerovic D, Tanovic AT, Dzankovic F, Campara MT. The Effect of Prehabilitation on Postoperative Outcome in Patients Following Primary Total Knee Arthroplasty. Med Arch. 2018 Dec;72(6):439-443. doi: 10.5455/medarh.2018.72.439-443.
PMID: 30814777BACKGROUNDdas Nair R, Mhizha-Murira JR, Anderson P, Carpenter H, Clarke S, Groves S, Leighton P, Scammell BE, Topcu G, Walsh DA, Lincoln NB. Home-based pre-surgical psychological intervention for knee osteoarthritis (HAPPiKNEES): a feasibility randomized controlled trial. Clin Rehabil. 2018 Jun;32(6):777-789. doi: 10.1177/0269215518755426. Epub 2018 Feb 9.
PMID: 29424236BACKGROUNDChao J, Jing Z, Xuehua B, Peilei Y, Qi G. Effect of Systematic Exercise Rehabilitation on Patients With Knee Osteoarthritis: A Randomized Controlled Trial. Cartilage. 2021 Dec;13(1_suppl):1734S-1740S. doi: 10.1177/1947603520903443. Epub 2020 Feb 10.
PMID: 32037857BACKGROUNDBennell KL, Nelligan RK, Kimp AJ, Schwartz S, Kasza J, Wrigley TV, Metcalf B, Hodges PW, Hinman RS. What type of exercise is most effective for people with knee osteoarthritis and co-morbid obesity?: The TARGET randomized controlled trial. Osteoarthritis Cartilage. 2020 Jun;28(6):755-765. doi: 10.1016/j.joca.2020.02.838. Epub 2020 Mar 19.
PMID: 32200051BACKGROUNDPedersen BK, Saltin B. Exercise as medicine - evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015 Dec;25 Suppl 3:1-72. doi: 10.1111/sms.12581.
PMID: 26606383BACKGROUNDKoffel E, Kats AM, Kroenke K, Bair MJ, Gravely A, DeRonne B, Donaldson MT, Goldsmith ES, Noorbaloochi S, Krebs EE. Sleep Disturbance Predicts Less Improvement in Pain Outcomes: Secondary Analysis of the SPACE Randomized Clinical Trial. Pain Med. 2020 Jun 1;21(6):1162-1167. doi: 10.1093/pm/pnz221.
PMID: 31529104BACKGROUNDAlghadir AH, Anwer S, Sarkar B, Paul AK, Anwar D. Effect of 6-week retro or forward walking program on pain, functional disability, quadriceps muscle strength, and performance in individuals with knee osteoarthritis: a randomized controlled trial (retro-walking trial). BMC Musculoskelet Disord. 2019 Apr 9;20(1):159. doi: 10.1186/s12891-019-2537-9.
PMID: 30967128BACKGROUNDGao B, Li L, Shen P, Zhou Z, Xu P, Sun W, Zhang C, Song Q. Effects of proprioceptive neuromuscular facilitation stretching in relieving pain and balancing knee loading during stepping over obstacles among older adults with knee osteoarthritis: A randomized controlled trial. PLoS One. 2023 Feb 13;18(2):e0280941. doi: 10.1371/journal.pone.0280941. eCollection 2023.
PMID: 36780435BACKGROUNDUghi N, Prevete I, Ramonda R, Cavagna L, Filippou G, Manara M, Bortoluzzi A, Parisi S, Ariani A, Scire CA. The Italian Society of Rheumatology clinical practice guidelines for the diagnosis and management of gout. Reumatismo. 2019 Sep 23;71(S1):50-79. doi: 10.4081/reumatismo.2019.1176.
PMID: 31948193BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
IRENE MARIA IMLP LOPERA PAREJA, PRINCIPAL INVESTIGATOR
University of Jaen
- PRINCIPAL INVESTIGATOR
IRENE MARIA IM LOPERA, Investigator
University of Jaen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 28, 2024
First Posted
December 6, 2024
Study Start
May 15, 2025
Primary Completion (Estimated)
November 30, 2026
Study Completion (Estimated)
January 31, 2027
Last Updated
February 13, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
- Time Frame
- January 2025- January 2026
- Access Criteria
- Access Criteria for IPD Sharing: Research Purpose: Access is granted solely for valid scientific research that aligns with the objectives of the original study or advances medical knowledge. Application Requirements: Applicants must submit a detailed research proposal, including objectives, methodology, and justification for using the requested data. Researcher Qualifications: Access is limited to qualified researchers affiliated with recognized institutions. Data Use Agreement (DUA): Applicants must sign a DUA, agreeing to use the data only for the approved purpose, maintain confidentiality, and avoid re-identification of participants. Ethical Compliance: The research must have ethics committee approval and comply with relevant legal and regulatory standards. Transparency: Researchers must commit to publishing results in peer-reviewed journals or other scientific forums.
Plan for Sharing IPD from a Clinical Trial: 1. Objective: Promote transparency, reproducibility, and new knowledge generation while safeguarding participant confidentiality. 2. Ethical and legal aspects: Verify informed consent, de-identify data, and comply with regulations (e.g., GDPR, HIPAA). 3. Preparation: Review and anonymize data, accompanied by key documentation (data dictionary, protocol, CSR). 4. Infrastructure: Use secure platforms (e.g., Vivli, ClinicalStudyDataRequest) with access controls and traceability. 5. Access: Review requests based on clear criteria; require data use agreements (DUA) and ethical commitment from researchers. 6. Timeline: Share data 6-12 months after publication, available for 5-10 years. 7. Oversight: Monitor requests and compliance; assess impact and adjust the plan based on feedback.